Psoriasis
News
Methotrexate Cuts Anti-Adalimumab Antibody Production
Major Finding: Patients on a high methotrexate dose had an 85% reduction in their incidence of an immune reaction to adalimumab, compared with...
News
Early Data Find No Adalimumab Teratogenicity
News
Consider Intraocular Infliximab in Behçet's Disease Uveitis
Major Finding: A single intravitreal injection of 1 mg of infliximab resulted in significant reductions in ocular inflammation as well as improved...
Conference Coverage
Psoriatic Arthritis Screening Tests Deemed Inadequate
Major Finding: Three popular screening tests for psoriatic arthritis in patients with psoriasis displayed suboptimal specificities of 45%-55% in a...
Conference Coverage
Tocilizumab Beats Adalimumab in Monotherapy RA Trial
Conference Coverage
Ixekizumab Normalizes Mutant Psoriasis Genes
Major Finding: Ixekizumab resulted in a greater-than-75% normalization of expression of 643 inflammatory genes, compared with 104 with etanercept...
News
Myeloma Drug Tamed Refractory Systemic Lupus Erythematosus
Major Finding: All 13 patients with refractory SLE who were treated with two to four cycles of the proteasome inhibitor bortezomib responded with...
Commentary
New Anti-Inflammatory Drugs Will End Anti-TNF Dominance
News
Behçet's Disease Presentation Varies by Gender
News
Most Cancers Not Elevated in Vasculitis
Major Finding: Patients with circulating antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis had a 2.78-fold greater incidence of...
Conference Coverage
Certolizumab Eased Skin and Joint Symptoms in PsA
Major Finding: An ACR 20 response at 12 weeks was documented in 58% of PsA patients who were randomized to the pegylated TNF inhibitor...